Tag : Biologic

Cardiology

Clinical Outcomes after Biologic Graft Use for the Creation of Blalock-Taussig Shunt in Critically Ill Patients with Thrombophilia.

Newsemia
Related Articles Clinical Outcomes after Biologic Graft Use for the Creation of Blalock-Taussig Shunt in Critically Ill Patients with Thrombophilia. Heart Surg Forum. 2020 Oct...
Latest News

Biologic or targeted synthetic DMARDs reduce dementia in patients with rheumatoid arthritis

Newsemia
The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease modifying antirheumatic drugs (DMARDs) than in...
Latest News

Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope

Newsemia
Tillett, W; Allen, A; Tucker, L; Chandler, D; Ciurtin, C; Davis, C; Dick, A; … Coates, LC; + view all Tillett, W; Allen, A; Tucker,...
Latest News

Biologic Predictors of Extension of Oligoarticular Juvenile Idiopathic Arthritis as Determined From Synovial Fluid Cellular Composition and Gene Expression

Newsemia
Hunter, PJ; Nistala, K; Jina, N; Eddaoudi, A; Thomson, W; Hubank, M; Wedderburn, LR; (2010) Biologic Predictors of Extension of Oligoarticular Juvenile Idiopathic Arthritis as...
Dermatology

Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study.

Newsemia
Related Articles Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study. J...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy